Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.54 +0.07 (+2.02%)
As of: Oct 2, 2026 · 1:01 PM EDT

Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Insight Molecular Diagnostics' Depreciation & Amortization (CF) came in at $665,000 for Q2 2026, up 19.0% from $559,000 a year earlier and up 5.4% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Insight Molecular Diagnostics reported Depreciation & Amortization (CF) of $2.45 million, up 22.8% year-over-year; for FY2025, it came in at $2.2 million, up 40.7% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 47.7% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $1.56 million in FY2024 (-2.3%), $1.6 million in FY2023 (+6.7%), $1.5 million in FY2022 (+87.5%) and $800,000 in FY2021 (+155.6%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2015.
  • Year-over-year, Depreciation & Amortization (CF) increased in six of the last eight quarters, with growth averaging 43.9%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2021 (growth of 269.6%), and the weakest in Q1 2024 (a decline of 30.4%).
  • Business Quant data shows IMDX's Depreciation & Amortization (CF) at $631,000 (Q1 2026), $573,000 (Q4 2025) and $584,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 331.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 402.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 196.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 192.30 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 729.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 121.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 355.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 42.70 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 564.00 Mn
10 Insight Molecular Diagnostics 117.12 Mn 40.83 Mn 157,000.00 665,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 665,000.00
Mar 31, 2026 631,000.00
Dec 31, 2025 573,000.00
Sep 30, 2025 584,000.00
Jun 30, 2025 559,000.00
Mar 31, 2025 491,000.00
Dec 31, 2024 629,000.00
Sep 30, 2024 318,000.00
Jun 30, 2024 304,000.00
Mar 31, 2024 313,000.00
Dec 31, 2023 300,000.00
Sep 30, 2023 404,000.00
Jun 30, 2023 435,000.00
Mar 31, 2023 450,000.00
Dec 31, 2022 400,000.00
Sep 30, 2022 391,000.00
Jun 30, 2022 384,000.00
Mar 31, 2022 287,000.00
Dec 31, 2021 218,000.00
Sep 30, 2021 255,000.00
API Access

Insight Molecular Diagnostics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=IMDX&period=max&api_key=YOUR_API_KEY